Patents Represented by Attorney, Agent or Law Firm Robert W. Black
  • Patent number: 6346517
    Abstract: This invention is directed to a combination therapy comprising the administration of a low molecular weight heparin such as tinzaparin and a platelet GPIIb/IIIa antagonist such as roxifiban for treating, preventing and reducing the risk of thromboembolic disorders.
    Type: Grant
    Filed: March 10, 2000
    Date of Patent: February 12, 2002
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventors: Pancras C. Wong, Shaker A. Mousa
  • Patent number: 6342503
    Abstract: The present invention provides novel compounds, compounds and pharmaceutical compositions thereof, and methods of using same in the treatment of affective disorders, anxiety, depression, post-traumatic stress disorders, eating disorders, supranuclear palsy, irritable bowel syndrome, immune suppression, Alzheimer'disease, gastrointestinal diseases, anorexia nervosa, drug and alcohol withdrawal symptoms, drug addiction, inflammatory disorders, or fertility problems. The novel compounds provided by this invention are those of formula: wherein R1, R3, R4, R5, Z, Y, V, X, X′, J, K, L, and M are as defined herein.
    Type: Grant
    Filed: January 7, 1998
    Date of Patent: January 29, 2002
    Assignee: DuPont Pharmaceuticals Company
    Inventors: Paul Edward Aldrich, Argyrios Georgios Arvanitis, Robert Scott Cheeseman, Robert John Chorvat, Thomas Eugene Christos, Paul Joseph Gilligan, Dimitri Emil Grigoriadis, Carl Nicholas Hodge, Paul John Krenitsky, Everett Latham Scholfield, Sang William Tam, Zelda Rakowitz Wasserman
  • Patent number: 6136833
    Abstract: Provided is a pharmaceutical composition comprising a tablet or capsule containing a pharmacologically effective amount of a pharmaceutical compound, or a pharmaceutically acceptable salt thereof, having an amidine-based group and an optional ester group, a pharmaceutically acceptable solid carrier, and a pharmaceutically acceptable acid in an amount to modify the pH of the composition to substantially that of the compound at pH of maximum stability.Such a composition is prepared by adding water during formulation manufacture and contacting the compound during formulation manufacture with a pharmaceutically acceptable acid having a pH in a saturated aqueous solution substantially that of the compound at pH of maximum stability.
    Type: Grant
    Filed: January 11, 1999
    Date of Patent: October 24, 2000
    Assignee: Dupont Pharmaceuticals Company
    Inventors: Sherif Ibrahim Farag Badawy, Donna Lynn Gilbert
  • Patent number: 5641934
    Abstract: See-through, hand-held, bullet-resistant shields are disclosed which provide life-saving upper body protection for a police officer, shopkeeper, bank teller or any person holding said shield, or standing or ducking behind said shield when substantially vertically mounted on the side of a counter top surface. Such shields are formed from a totally see-through or substantially transparent (no lens) bullet-resistant sheet material, capable of being vertically disposed and of a size and shape so as to provide upper body frontal protection of at least a person's face, head, neck, forearm, hand and upper chest anatomy; and has at least one hand-gripping means centrally attached to and spaced from one side of said transparent sheet.
    Type: Grant
    Filed: April 17, 1995
    Date of Patent: June 24, 1997
    Inventor: Harold Eugene Follett
  • Patent number: 5136961
    Abstract: A hydroplaning hydrofoil and airfoil planing or flying wing structure is disclosed based on the concept of forward-swept planes or planar surfaces having swept-back fore foil sections and forward-swept aft foil sections upon which the hydrofoil/airfoil structure optionally supports itself and planes on or through a fluid preferably either water or air. Also disclosed are aquatic structures or watercraft to which the hydroplaning hydrofoil/airfoil structures are optionally attached. In addition, light weight amphibious structures are disclosed; preferably these structures are sail, engine, or electric motor powered craft to which the hydroplaning hydrofoil/airfoil structures are optionally attached.
    Type: Grant
    Filed: December 21, 1989
    Date of Patent: August 11, 1992
    Inventor: Harold E. Follett
  • Patent number: 5039690
    Abstract: Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives, such as l-N-[3-(2,3-dihydro-oxa or thio-lH-inden-5-yl)-2-oxooxazolidin-5-ylmethyl]acetamide, possess useful antibacterial activity.
    Type: Grant
    Filed: March 15, 1990
    Date of Patent: August 13, 1991
    Assignee: Du Pont Merck Pharmaceutical Company
    Inventors: Chia-Lin J. Wang, Mark A. Wuonola
  • Patent number: 5036093
    Abstract: Aminomethyl oxooxazolidinyl azacycloalkylbenzene derivatives, such as l-N-[3-(2,3-dihydro-3-aza-1H-inden-5-yl)-2-oxooxazolidin-5-ylmethyl]acetam ide, possess useful antibacterial activity.
    Type: Grant
    Filed: March 15, 1990
    Date of Patent: July 30, 1991
    Assignee: Du Pont Merck Pharmaceutical
    Inventors: Chia-Lin J. Wang, Mark A. Wuonola
  • Patent number: 5036092
    Abstract: Aminomethyl oxooxazolidinyl aza cycloalkylbenzene derivatives, such as l-N-[3-(2,3-dihydro-3-aza-1H-inden-5-yl)-2-oxooxazolidin-5-ylmethyl]acetam ide, possess useful antibacterial activity.
    Type: Grant
    Filed: March 15, 1990
    Date of Patent: July 30, 1991
    Assignee: Du Pont Merck Pharmaceutical
    Inventors: Chia-Lin J. Wang, Mark A. Wuonola
  • Patent number: 5032605
    Abstract: Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives, such as l-N-[3-(2,3-dihydro-oxa or thia-1H-inden-5-yl)-2-oxooxazolidin-5-ylmethyl]acetamide, possess useful antibacterial activity.
    Type: Grant
    Filed: March 15, 1990
    Date of Patent: July 16, 1991
    Assignee: Du Pont Merck Pharmaceutical Company
    Inventors: Chia-Lin J. Wang, Mark A. Wuonola
  • Patent number: 4977173
    Abstract: Aminomethyl oxooxazolidinyl ethenylbenzene derivatives, including the nitriles, sulfoxides, acetamides and nitro compounds, such as l-N-[3-[4-(E-1-methyl-2-cyanoethenyl)phenyl]-2-oxooxazolidin-5-ylmethyl]ac etamide, possess useful antibacterial activity.
    Type: Grant
    Filed: July 7, 1989
    Date of Patent: December 11, 1990
    Assignee: E. I. Du Pont de Nemours and Company
    Inventors: David R. Brittelli, Peter F. Corless, Walter A. Gregory, Chung-Ho Park
  • Patent number: 4942183
    Abstract: Aminomethyl oxooxazolidinyl aroylbenzene derivatives, such as l-N-[3-[4-(2,4-difluorobenzoyl)phenyl]-2-oxooxazolidin-5-ylmethyl]acetamid e, possess useful antibacterial activity.
    Type: Grant
    Filed: July 7, 1989
    Date of Patent: July 17, 1990
    Assignee: E. I. Du Pont de Nemours and Company
    Inventors: Walter A. Gregory, Hollis S. Kezar, III
  • Patent number: 4868181
    Abstract: 1,4-Dihydropyridine derivatives which combine both calcium agonist and alpha.sub.1 -antagonist activity are useful in treating congestive heart failure. These derivatives are compounds having the formula: ##STR1## wherein Ar, R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are defined in the specification.
    Type: Grant
    Filed: June 30, 1987
    Date of Patent: September 19, 1989
    Assignee: E. I. Du Pont de Nemours and Company
    Inventors: Alexander L. Johnson, Philip Ma, Petrus B. M. W. M. Timmermans, Ruth R. Wexler
  • Patent number: 4760083
    Abstract: Cognitive deficiencies and/or neurological function deficits and/or mood and/or mental disturbances are treated by the administration of 3,3-disubstituted indolines. The indolines have the formula: ##STR1## wherein: p is 0 or 1;Z is O or S;R is C.sub.1 -C.sub.10 alkyl, C.sub.3 -C.sub.8 cycloalkyl, 2-pyridyl, 3-pyridyl, 4-pyridyl or ##STR2## V, W, X, and Y independently are H, halo, C.sub.1 -C.sub.3 alkyl, OR.sup.1, NO.sub.2, CF.sub.3, CN or NR.sup.2 R.sup.2 ;R.sup.1 and R.sup.2 independently are H or C.sub.1 -C.sub.3 alkyl;-- .circle.H and -- .circle.H' independently are 6-membered heterocyclic aromatic rings containing at least one nitrogen atom as a part of the ring optionally substituted with one substituent selected from the group C.sub.1 -C.sub.3 alkyl, halo, OR.sup.1 or NR.sup.1 R.sup.2 ; oran N-oxide or pharmaceutically suitable acid addition salt thereof.
    Type: Grant
    Filed: January 5, 1987
    Date of Patent: July 26, 1988
    Assignee: E. I. Dupont de Nemours & Company
    Inventors: Melvyn J. Myers, Victor J. Nickolson